Metastic Prostate Cancer: New Studies Indicate Improvement with PC Hope
this press release as an Adobe PDF document
Two new studies indicate that for men with prostate cancer, PC Hope is
associated with significant improvements in quality of life, reductions in
patients’ pain rating, and a decline in PSA levels without major side effects.
(PRWEB) November 18, 2004 -- Nutrition 2000 is proud to announce the results
of two recent studies conducted on the formulation of its product for
prostate cancer, PC Hope. PC Hope, a dietary supplement containing various
sitosterols, quercetin and sterolins, extracts from Saw Palmetto, Scutellaria,
Ginseng, Skullcap, Reishi, Ginger, Stinging Nettle and Pygeum, is becoming
popular among patients with
prostate cancer and can be used as complementary treatment in various stages
of the disease.
prostate cancer studies led in by Dr U. Kratzer of the Urology Clinic in
Trostberg, Germany, and Dr. B. Pfeifer of the Aeskulap Cancer Center in Brunnen,
Switzerland, conclude that the herbal blend in PC Hope significantly reduces PSA
and pain of metastatic disease, thereby improving quality of life for
prostate cancer patients without the detrimental side effects seen with
other drug regimens.
The first study, initiated in December 2001, evaluated a total of 84 men between
the ages of 56 and 75 with ablation-resistant metastatic
prostate cancer for possible toxic and beneficial effects from using the PC
Hope formulation. The men received supplemental treatment with PC Hope
formulation (2700 mg daily for the first month, 1800mg daily for the second
month, 1200 mg daily in the third month, and between 900 to 1200 mg from the
fourth month on) for a total follow-up of 16 months. Hormonal therapy was
continued throughout the trial to avoid the known withdrawal effect of
anti-androgen on PSA. The study revealed that 60% of the 84
prostate cancer patients reported improvement of at least 30% in their
overall daily functioning.
A second study, aimed at determining clinical efficacy and side effect profile
of the PC Hope formulation intake, was evaluated prospectively utilizing
prostate cancer patient questionnaires, physician-patient interviews, and
laboratory data analysis during a 12 month follow-up period of 178 men between
the ages of 52 and 75. About half of the study patients (88) had undergone
radical prostatectomy as initial treatment for their
prostate cancer followed by hormone ablative therapy upon recurrence of
their disease or metastasis. Slightly more than one quarter of the
prostate cancer patients (46) had prior external radiation therapy followed
by hormone ablative therapy, and the remainder of the
prostate cancer patients (44) underwent either surgical or chemical
castration as their initial therapy.
The study indicated that about two-thirds of the hormone refractory
prostate cancer patients responded with a greater than 50% reduction in
their serum PSA levels. Furthermore, at least 20% responded not only with a
durable PSA decline under the PC Hope formulation therapy, but also showed
evidence of decreasing volume of primary
prostate cancer and metastases. Although research revealed about 20% of the
prostate cancer patients reported a slight increase of the breasts, in
particular at the higher dosage of the PC Hope formulation during the first two
months of the study, the breast enlargement was usually reversible during the
remainder of the study period when a lower maintenance dosage of the PC Hope
formulation was administered.
Larry Pope, President of Nutrition 2000, says, “Although the results are
promising, we don’t want the public to think that PC Hope is a magic bullet.
Nevertheless, it is an effective alternative for
prostate cancer patients.”
Patients with hormone refractory
prostate cancer are reported to have a median survival of six to twelve
months, experts say. Experts also report that current therapeutic regimens for
prostate cancer have only shown transient palliative benefit without
increasing patient survivals, and most of these palliative therapies have
significant side effects.
Prostate cancer patients with such dismal prognoses are prone to seek
alternative treatments, including herbal remedies. Among such remedies, PC Hope
has gained popularity due to anecdotal reports about its benefits for hormone
prostate cancer patients. The results of both studies verify some of those
claimed benefits. For more detailed information concerning these studies or to
learn more about PC Hope please visit
or call 1-800-558-9697.
About Nutrition 2000
Nutrition 2000 offers some of the world's finest natural health products, herbal
remedies, and supplements for the treatment of
prostate cancer, pancreatic cancer, colon cancer, Candida, and more.
Stocking a carefully selected range of products made from the highest quality
herbal extracts and pharmaceutical-grade nutrient powders, they provide
alternative natural remedies to combat illnesses and common ailments. Nutrition
2000 delivers their message and products to the United States, United Kingdom,
and other countries around the world.
# # #
This press release was posted by the following PR Firm
Xeal Precision Marketing
Other Releases by this Member